In a new statement, the EU regulatory authority EMA postulates that AstraZeneca’s vaccine causes serious deep vein thrombosis.

The regulatory situation regarding the trade of medicinal cannabis currently varies enormously from country to country within the European Union. Unfortunately, there is still no full regulatory harmonization on a European level.

German structural biologists have identified seven compounds that neutralise SARS-CoV-2 by targeting Mpro, the virus’ main protease.

Researchers in Italy have identified a pair of microRNA molecules, miR-146A and miR-, help maintain a population of breast cancer stem cells

Effective bioprocess development starts with the targeted and time-saving generation of high-productivity strains already considering economic target values and regulatory requirements. The UNLOCK PICHIA technology platform comprises a large number of versatile expression tools for the generation and identification of effective industrial protein production strains without compromising development timelines.

Innovators at Rentschler Biopharma are continuously developing new processes for biopharmaceutical production to tackle life-threatening diseases. Two of them, Dr Birgit Ehrenberg, Process Manager, and Monika Häußler, Quality Control (QC) Manager, shared insights into their latest projects and how close collaboration with chromatography experts from Tosoh Bioscience helped them develop robust, scalable, and economically viable downstream processes, as well as corresponding reliable bioanalytical methods.

Johnson & Johnson subsidiary Janssen Pharmaceutica NV has confirmed to deliver 220 million doses of its COVID-19 vaccine to the African Vaccine Acquisition Trust (AVAT).

A bispecific antibody designed by a Swiss-Czech research team suppressed viral escape of SARS-CoV-2 variants in animals.

At the beginning of March, Dr Sophie Biguenet has been the new Chief Medical Officer of Paris-based Abivax SA.

The 11th edition of the European Biotechnology Science & Industry Guide once more offers an interesting cross-section of the European biotech scene.